動物用藥品市場分析及預測（至2035年）：依類型、產品、服務、技術、應用、形式、最終用戶及設備分類

預計動物用藥品市場規模將從2024年的456億美元成長到2034年的782億美元，年複合成長率約為5.2%。動物用藥品市場涵蓋專門用於動物健康的藥品、疫苗和醫療設備。該行業致力於伴侶動物和牲畜的護理，並專注於疾病預防、治療和健康促進。市場的主要促進因素包括寵物主人數量的增加、獸醫治療方法的進步以及畜牧業產量的成長。生物製藥和個人化醫療的創新，以及監管政策的發展，對於推動市場成長和機會至關重要。

動物用藥品市場正經歷強勁成長，這主要得益於動物保健技術的進步和寵物飼養率的上升。其中，藥品細分市場成長率最高，主要得益於抗寄生蟲藥和抗感染藥在疾病預防和治療中的重要作用。疫苗細分市場緊隨其後，其成長動力來自意識提升以及對抗通用感染疾病的需求。診斷細分市場成長率位居第二，其中臨床生物化學檢驗和免疫診斷展現出巨大的潛力。這些細分市場對於疾病的早期發現和管理至關重要，有助於改善動物健康。伴侶動物診斷細分市場尤其受到關注，反映出人們對寵物健康管理的日益重視。就地檢驗和數位成像診斷等技術創新進一步推動了市場成長。遠端醫療和移動獸醫服務的興起也為滿足寵物飼主和動物飼養管理者不斷變化的需求提供了盈利的機會。該行業對永續發展和精準醫療的關注將繼續塑造其未來的發展軌跡。

由於定價策略的多樣化和創新產品推出，動物用藥品市場正經歷市場佔有率的動態變化。主要企業正致力於透過推出先進的藥品和生物製藥來拓展產品系列。這一趨勢的驅動力在於不斷成長的動物保健需求以及人們對通用感染疾病意識提升。各公司也正在採用具競爭力的定價模式來拓展更廣大的消費群。這種環境為新參與企業和現有企業都創造了有利的市場條件，有望帶來強勁的成長和創新。動物用藥品市場的競爭異常激烈，主要企業相互參照，以維持和鞏固其市場地位。監管的影響至關重要，嚴格的指導方針影響產品開發和核准流程。北美和歐洲憑藉其成熟的獸醫實踐和法規結構，仍然是重要的市場。同時，受寵物飼養和畜牧業發展推動，亞太新興市場正經歷快速成長。在這種競爭激烈且嚴格監管的環境下，策略靈活性和合規性對於抓住快速成長機會至關重要。

主要趨勢和促進因素：

受寵物主人數量不斷成長和動物健康意識提升日益增強的推動，動物用藥品市場正經歷強勁成長。隨著寵物飼主更積極主動管理寵物健康，預防性照護（包括定期體檢和疫苗接種）的普及率不斷提高。這種轉變推動了對獸醫服務和藥品的需求，刺激了市場擴張。科技創新正在改變這個產業，遠端醫療和穿戴式動物健康監測設備等新技術正日益普及。這些技術提供便利和即時健康訊息，吸引了精通技術的消費者，並提高了獸醫護理的品質。此外，人們對伴侶動物健康的日益關注促使研發投入增加，新產品不斷推出，治療方法方案也更加多樣化。同時，由於全球肉類消費量的成長和對高效疾病管理的需求，畜牧業也經歷了顯著成長。這種需求推動了獸藥治療和診斷市場的發展。新興市場蘊藏著眾多機遇，這些市場中可支配收入的增加和都市化的加速正在推動寵物飼養和畜牧業的發展。能夠提供創新、經濟高效的解決方案的公司，將更有利於利用這些趨勢，並推動未來的市場成長。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

• 宏觀經濟分析
• 市場趨勢
• 市場促進因素
• 市場機遇
• 市場限制
• 複合年均成長率：成長分析
• 影響分析
• 新興市場
• 技術藍圖
• 戰略框架

第4章 細分市場分析

• 市場規模及預測：依類型
  • 製藥
  • 生物製藥
  • 藥用飼料添加劑
• 市場規模及預測：依產品分類
  • 疫苗
  • 驅蟲藥
  • 抗感染劑
  • 藥用飼料添加劑
  • 診斷產品
• 市場規模及預測：依服務分類
  • 獸醫醫院和診所
  • 檢查服務
  • 遠端醫療
• 市場規模及預測：依技術分類
  • 基因組檢測
  • 生物技術
  • 奈米科技
• 市場規模及預測：依應用領域分類
  • 伴侶動物
  • 家畜
  • 水生動物
• 市場規模及預測：依類型
  • 藥片
  • 注射
  • 粉末
  • 液體
• 市場規模及預測：依最終用戶分類
  • 動物診所
  • 獸醫診所
  • 研究所
• 市場規模及預測：依設施分類
  • 手術器械
  • 診斷設備
  • 監控設備
  • 治療設備

第5章 區域分析

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲
• 亞太地區
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲
  • 台灣
  • 亞太其他地區
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 義大利
  • 其他歐洲
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 撒哈拉以南非洲
  • 其他中東和非洲地區

第6章 市場策略

• 需求與供給差距分析
• 貿易和物流限制
• 價格、成本和利潤率趨勢
• 市場滲透率
• 消費者分析
• 法規概述

第7章 競爭訊息

• 市場定位
• 市場占有率
• 競爭基準
• 主要企業的策略

第8章：公司簡介

• Virbac
• Vetoquinol
• Dechra Pharmaceuticals
• Boehringer Ingelheim Animal Health
• Zoetis
• Elanco Animal Health
• Merck Animal Health
• Ceva Sante Animale
• Bayer Animal Health
• Merial
• Norbrook
• Phibro Animal Health
• Huvepharma
• KRKA Animal Health
• Hipra
• Biogenesis Bago
• Kyoritsu Seiyaku
• Neogen Corporation
• IDEXX Laboratories
• Ourofino Saude Animal

第9章：關於我們

Veterinary Medicine Market is anticipated to expand from $45.6 billion in 2024 to $78.2 billion by 2034, growing at a CAGR of approximately 5.2%. The Veterinary Medicine Market encompasses pharmaceuticals, vaccines, and medical devices tailored for animal health. This sector addresses companion and livestock animal care, focusing on disease prevention, treatment, and wellness. Key drivers include rising pet ownership, advancements in veterinary therapeutics, and increasing livestock production. Innovation in biologics and personalized medicine is pivotal, alongside regulatory advancements, enhancing market growth and opportunities.

The Veterinary Medicine Market is experiencing robust growth, propelled by advancements in animal healthcare and rising pet ownership. The pharmaceuticals segment is the top performer, with parasiticides and anti-infectives leading due to their critical role in disease prevention and treatment. The vaccines sub-segment follows closely, driven by increasing awareness of preventive healthcare and the need to combat zoonotic diseases. The diagnostics segment is the second highest performing, with clinical biochemistry and immunodiagnostics showing significant promise. These sub-segments are essential for early disease detection and management, enhancing animal health outcomes. Companion animal diagnostics are particularly gaining traction, reflecting the growing emphasis on pet wellness. Technological innovations, such as point-of-care testing and digital imaging, are further propelling market growth. The rise of telemedicine and mobile veterinary services also presents lucrative opportunities, catering to the evolving needs of pet owners and livestock managers. The industry's focus on sustainable practices and precision medicine continues to shape its future trajectory.

The Veterinary Medicine Market is experiencing a dynamic shift in market share, with diverse pricing strategies and innovative product launches. Key players are focusing on expanding their portfolios by introducing advanced pharmaceuticals and biologics. This trend is driven by the rising demand for animal healthcare and the increasing awareness of zoonotic diseases. Companies are also adopting competitive pricing models to capture a larger consumer base. This environment fosters a rich landscape for new entrants and established firms alike, promising robust growth and innovation. Competition within the Veterinary Medicine Market is intense, with leading firms benchmarking against each other to maintain and enhance their market positions. Regulatory influences play a crucial role, with stringent guidelines affecting product development and approval processes. North America and Europe remain significant markets due to established veterinary practices and regulatory frameworks. Meanwhile, emerging markets in Asia-Pacific are witnessing rapid growth, fueled by increasing pet ownership and livestock farming. This competitive and regulatory landscape necessitates strategic agility and compliance to capitalize on burgeoning opportunities.

Geographical Overview:

The veterinary medicine market is witnessing notable growth, with regional dynamics playing a crucial role. North America remains at the forefront, driven by advanced healthcare infrastructure and increasing pet ownership. The region's emphasis on innovation and research significantly contributes to its market leadership. Europe follows, with robust veterinary healthcare policies and a strong focus on animal welfare fueling market expansion. Asia Pacific is emerging as a promising growth pocket. Rising disposable incomes and pet adoption rates are key drivers in this region. Countries like China and India are experiencing rapid market growth, bolstered by increased awareness of animal health. Latin America is also gaining traction, with Brazil and Mexico leading the charge due to rising investments in veterinary services. The Middle East & Africa, though in nascent stages, show potential. Growing government initiatives and awareness campaigns are paving the way for future market opportunities in these regions.

Global tariffs and geopolitical tensions are intricately influencing the Veterinary Medicine Market, particularly in Japan, South Korea, China, and Taiwan. These nations are recalibrating strategies to mitigate tariff impacts, with Japan and South Korea focusing on enhancing local production capabilities. China is advancing its domestic veterinary pharmaceutical sector to reduce reliance on imports. Taiwan remains a vital player due to its advanced biotech capabilities but faces geopolitical vulnerabilities. The global veterinary medicine market is witnessing robust growth, driven by rising pet ownership and livestock health investments. By 2035, the market is projected to expand significantly, contingent upon resilient supply chains and strategic regional partnerships. Meanwhile, Middle East conflicts are exacerbating energy price volatility, indirectly affecting production costs and supply chain stability.

Key Trends and Drivers:

The veterinary medicine market is experiencing robust growth propelled by increased pet ownership and heightened awareness of animal health. There is a rising trend in the adoption of preventive care, which includes regular check-ups and vaccinations, as pet owners become more proactive in managing their pets' health. This shift is driving demand for veterinary services and pharmaceuticals, fostering market expansion. Technological advancements are revolutionizing the industry, with innovations such as telemedicine and wearable health monitoring devices for animals gaining traction. These technologies offer convenience and real-time health insights, appealing to tech-savvy consumers and enhancing veterinary care. Additionally, the growing focus on companion animal health is leading to increased investments in research and development, driving new product launches and treatment options. Furthermore, the livestock sector is witnessing significant growth due to rising global meat consumption and the need for efficient disease management. This demand is bolstering the market for veterinary therapeutics and diagnostics. Opportunities abound in emerging markets, where rising disposable incomes and urbanization are increasing pet ownership and livestock farming. Companies that can offer innovative, cost-effective solutions are well-positioned to capitalize on these trends and drive future market growth.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by Form
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Equipment

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Pharmaceuticals
  • 4.1.2 Biologicals
  • 4.1.3 Medicated Feed Additives
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Vaccines
  • 4.2.2 Parasiticides
  • 4.2.3 Anti-Infectives
  • 4.2.4 Medicinal Feed Additives
  • 4.2.5 Diagnostic Products
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Veterinary Hospitals and Clinics
  • 4.3.2 Laboratory Testing Services
  • 4.3.3 Telemedicine
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Genomic Testing
  • 4.4.2 Biotechnology
  • 4.4.3 Nanotechnology
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Companion Animals
  • 4.5.2 Livestock Animals
  • 4.5.3 Aquatic Animals
• 4.6 Market Size & Forecast by Form (2020-2035)
  • 4.6.1 Tablets
  • 4.6.2 Injectables
  • 4.6.3 Powders
  • 4.6.4 Liquids
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Veterinary Clinics
  • 4.7.2 Veterinary Hospitals
  • 4.7.3 Research Institutes
• 4.8 Market Size & Forecast by Equipment (2020-2035)
  • 4.8.1 Surgical Equipment
  • 4.8.2 Diagnostic Equipment
  • 4.8.3 Monitoring Equipment
  • 4.8.4 Therapeutic Equipment

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Application
    • 5.2.1.6 Form
    • 5.2.1.7 End User
    • 5.2.1.8 Equipment
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Application
    • 5.2.2.6 Form
    • 5.2.2.7 End User
    • 5.2.2.8 Equipment
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Application
    • 5.2.3.6 Form
    • 5.2.3.7 End User
    • 5.2.3.8 Equipment
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Application
    • 5.3.1.6 Form
    • 5.3.1.7 End User
    • 5.3.1.8 Equipment
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Application
    • 5.3.2.6 Form
    • 5.3.2.7 End User
    • 5.3.2.8 Equipment
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Application
    • 5.3.3.6 Form
    • 5.3.3.7 End User
    • 5.3.3.8 Equipment
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Application
    • 5.4.1.6 Form
    • 5.4.1.7 End User
    • 5.4.1.8 Equipment
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Application
    • 5.4.2.6 Form
    • 5.4.2.7 End User
    • 5.4.2.8 Equipment
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Application
    • 5.4.3.6 Form
    • 5.4.3.7 End User
    • 5.4.3.8 Equipment
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Application
    • 5.4.4.6 Form
    • 5.4.4.7 End User
    • 5.4.4.8 Equipment
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Application
    • 5.4.5.6 Form
    • 5.4.5.7 End User
    • 5.4.5.8 Equipment
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Application
    • 5.4.6.6 Form
    • 5.4.6.7 End User
    • 5.4.6.8 Equipment
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Application
    • 5.4.7.6 Form
    • 5.4.7.7 End User
    • 5.4.7.8 Equipment
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Application
    • 5.5.1.6 Form
    • 5.5.1.7 End User
    • 5.5.1.8 Equipment
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Application
    • 5.5.2.6 Form
    • 5.5.2.7 End User
    • 5.5.2.8 Equipment
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Application
    • 5.5.3.6 Form
    • 5.5.3.7 End User
    • 5.5.3.8 Equipment
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Application
    • 5.5.4.6 Form
    • 5.5.4.7 End User
    • 5.5.4.8 Equipment
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Application
    • 5.5.5.6 Form
    • 5.5.5.7 End User
    • 5.5.5.8 Equipment
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Application
    • 5.5.6.6 Form
    • 5.5.6.7 End User
    • 5.5.6.8 Equipment
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Application
    • 5.6.1.6 Form
    • 5.6.1.7 End User
    • 5.6.1.8 Equipment
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Application
    • 5.6.2.6 Form
    • 5.6.2.7 End User
    • 5.6.2.8 Equipment
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Application
    • 5.6.3.6 Form
    • 5.6.3.7 End User
    • 5.6.3.8 Equipment
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Application
    • 5.6.4.6 Form
    • 5.6.4.7 End User
    • 5.6.4.8 Equipment
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Application
    • 5.6.5.6 Form
    • 5.6.5.7 End User
    • 5.6.5.8 Equipment

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Virbac
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Vetoquinol
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Dechra Pharmaceuticals
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Boehringer Ingelheim Animal Health
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Zoetis
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Elanco Animal Health
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Merck Animal Health
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Ceva Sante Animale
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Bayer Animal Health
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Merial
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Norbrook
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Phibro Animal Health
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Huvepharma
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 KRKA Animal Health
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Hipra
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Biogenesis Bago
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Kyoritsu Seiyaku
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Neogen Corporation
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 IDEXX Laboratories
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Ourofino Saude Animal
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us